Talk:Ximelagatran
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ximelagatran.
|
Page title
[edit]In accordance with Wikipedia:WikiProject_Drugs naming policy, I propose we move this page to the INN melagatran. If you have any concern with this proposal, please discuss it on this page. Matt 21:41, 23 Dec 2004 (UTC)
- No, the oral form (prodrug) is ximelagatran, which has its own ATC code. JFW | T@lk 22:12, 23 Dec 2004 (UTC)
- It would, however, be useful to show the structure of melagatran ... Daen (talk) 12:39, 8 April 2009 (UTC)
A black day for all those hoping to be freed of the curse of frequent INRs and dose adjustments. Was it a coincidence that JAMA reported on BAY 59-7939 this week? JFW | T@lk 00:07, 16 February 2006 (UTC)
Moved from article
[edit]I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- Ed (Edgar181) 22:49, 3 February 2017 (UTC)
- [[File:Melagatran.png|600px]] Sobrera, L. A.; Castaner, J.; Drugs Future, 2002, 27, 201.
Start a discussion about improving the Ximelagatran page
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. You can use this page to start a discussion with others about how to improve the "Ximelagatran" page.